Table 1.

Summary of the mouse models used in this study and their associated phenotypes

NameGenotypeNHistological phenotypeMetsNEPC
NPp53-SB(−) Nkx3.1CreERT2/+; Ptenflox/flox; Trp53flox/flox; R26LSL-SB11/LSL-SB11 31 Poorly differentiated adenocarcinoma with sarcomatoid features 7/31 (22%) 1/31 (3%) 
NPp53-SB(+) Nkx3.1CreERT2/+; Ptenflox/flox; Trp53flox/flox; R26LSL-SB11/LSL-SB11; T2/Onc2 93 Poorly differentiated adenocarcinoma with sarcomatoid features and neuroendocrine differentiation 57/93 (61%) 32/84 (38%) 
NP-SB(−) Nkx3.1CreERT2/+; Ptenflox/flox; R26LSL-SB11/LSL-SB11 12 High-grade PIN, well-differentiated adenocarcinoma 0/12 (0%) 0/12 (0%) 
NP-SB(+) Nkx3.1CreERT2/+; Ptenflox/flox; R26LSL-SB11/LSL-SB11; T2/Onc2 18 High-grade PIN, well-differentiated adenocarcinoma 0/18 (0%) 0/18 (0%) 

Mets, metastasis; NEPC, neuroendocrine prostate cancer; PIN, prostatic intraepithelial neoplasia.

or Create an Account

Close Modal
Close Modal